Will we see the world's first approved NASH drug in 2020?

Will we see the world's first approved NASH drug in 2020?

Source: 
Fierce Biotech
snippet: 

Nonalcoholic steatohepatitis (NASH) has been among the closely watched indications in biotech since January 2014, when Intercept Pharmaceuticals lit a fire under the field with midphase data that sent its share price up 500%. Now, Intercept is on the cusp of delivering on the promise that caused investors to pile into the stock.